Halted: What's going on with Sigma shares today?

Sigma investors would be holding their breath right now.

| More on:
Man with his hand out the front, symbolising a trading halt.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's been a great day for the S&P/ASX 200 Index (ASX: XJO) so far this Wednesday. After a rough and wild session yesterday, the ASX 200 seems to be in full recovery mode, which is good news for investors. But not so much for anyone who owns Sigma Healthcare Ltd (ASX: SIG) shares. At least at first glance.

That's because Sigma Healthcare shares are not active on the ASX today. The healthcare stock closed at $3.03 a share yesterday after enjoying a 12.22% boost following the company's latest earnings report.

As we covered at the time, this was a very impressive update. Sigma informed investors that the unlisted Chemist Warehouse chain delivered a 13% rise in total sales to a record high of $5.15 billion over the first half of the 2025 financial year. Sigma is, of course, barrelling towards a full merger with Chemist Warehouse.

Even more luminous were Chemist Warehouse's profits. Sigma revealed that the pharmacy chain boosted its net profits before tax by a whopping 36.1% to $436.8 million.

It therefore wasn't too shocking to see investors push up the Sigma share price so enthusiastically yesterday.

But today, those shares are frozen at $3.03 each, with trading halted.

Sigma shares halted for crucial Chemist Warehouse merger vote

Yep, this morning, Sigma put out an ASX release just before market open. This release informed investors that Sigma had requested an "immediate implementation of a trading halt". Fortunately, the company provided a detailed explanation as to why this halt was being requested:

The trading halt is requested pending announcements relating to the outcome of the Sigma shareholder meeting and the Chemist Warehouse scheme meeting which will both be held today.

As you know, these meetings relate to the merger between Sigma and Chemist Warehouse, and the passing of certain resolutions at both meetings are conditions precedent to the implementation of the merger.

Sigma requests the trading halt to allow Sigma to manage its continuous disclosure obligations and to ensure that Sigma shares are not trading on an uninformed basis.

Investors have known that this shareholder meeting was to occur today for a while. Sigma's board has already unanimously recommended that shareholders give the deal the green light. That's after the final regulatory approvals were granted late last year. If shareholders vote to proceed with the Chemist Warehouse merger, it will be implemented on 12 February next month.

Given the euphoric response from investors since the merger was first proposed in late 2023, it would be surprising to see it fail this vote. Since December 2023, the Sigma share price has ballooned by roughly 300%, rising from under $1 a share to the $3.03 the company is frozen at today.

Sigma expects its shares to resume trading by tomorrow's session at the latest. At the current share price, the company has a market capitalisation of $4.94 billion.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

a young woman holds her hand to her ear and leans sideways as if to listen to something that's surprising her as her eyes and her mouth are wide open.
Healthcare Shares

Down 15% since January, are Cochlear shares now a buy?

Let's see what analysts are saying about this blue chip.

Read more »

Green arrow with green stock prices symbolising a rising share price.
Healthcare Shares

Guess which popular ASX 200 stock is up nearly 60% in less than 2 months?

Investors who bought this ASX 200 stock in the recent dip have been strongly rewarded.

Read more »

A senior pharmacist talks to a customer at the counter in a shop.
Healthcare Shares

Are Sigma Healthcare shares a good buy now after the merger with Chemist Warehouse?

Sigma Healthcare shares have soared 154% in 12 months. Can this stellar run continue?

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

Up 34% since April, ASX 300 healthcare stock lifts off again today on new milestone

The ASX 300 healthcare stock has been on a tear since hitting one-year lows in April.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Should I buy the dip on CSL shares?

A leading fund manager gives his verdict on the growth prospects for CSL shares.

Read more »

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Healthcare Shares

NIB shares have soared 24% this year. Does Macquarie expect this to continue?

Will this private health insurer continue to deliver big returns? Let's find out.

Read more »

Woman presenting financial report on large screen in conference room.
Healthcare Shares

Up nearly 30% in a year, should I buy Fisher & Paykel shares before its earnings result?

Will the ASX 200 healthcare stock continue to outperform?

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

CSL shares among most expensive on ASX. Is now a good time to buy?

Analysts predict CSL share price growth will keep on coming.

Read more »